Hancock Jaffe Laboratories, Inc. (HJLI) financial statements (2021 and earlier)

Company profile

Business Address 70 DOPPLER
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments913
Cash and cash equivalents913
Receivables  0
Other undisclosed current assets000
Total current assets:1013
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment000
Intangible assets, net (including goodwill)  1
Intangible assets, net (excluding goodwill)  1
Restricted cash and investments 1 
Other undisclosed noncurrent assets000
Total noncurrent assets:121
TOTAL ASSETS:1134
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities321
Accounts payable111
Accrued liabilities100
Deferred revenue0 
Debt00 
Other undisclosed current liabilities00 
Total current liabilities:321
Noncurrent Liabilities
Long-term debt and lease obligation01 
Operating lease, liability01
Other undisclosed noncurrent liabilities(0)  
Total noncurrent liabilities:01 
Other undisclosed liabilities  0
Total liabilities:322
Stockholders' equity
Stockholders' equity attributable to parent712
Common stock000
Additional paid in capital725751
Accumulated deficit(65)(56)(49)
Total stockholders' equity:712
TOTAL LIABILITIES AND EQUITY:1134

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit: 00
Operating expenses(9)(8)(7)
Other undisclosed operating loss  (1)
Operating loss:(9)(8)(8)
Nonoperating income (expense)0(0)5
Other nonoperating expense(0)  
Interest and debt expense  (0)
Loss from continuing operations before income taxes:(9)(8)(3)
Income tax benefit  2
Net loss:(9)(8)(1)
Other undisclosed net income (loss) attributable to parent(0)0(12)
Net loss attributable to parent:(9)(8)(13)
Preferred stock dividends and other adjustments(1) (3)
Net loss available to common stockholders, diluted:(10)(8)(16)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(9)(8)(1)
Comprehensive loss, net of tax, attributable to parent:(9)(8)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: